Pasha Sarraf - SEC Form 4 Insider Trading Activity
Summary
Updated Aug 3, 2026
Pasha Sarraf has filed 1 SEC Form 4 filing across 1 company in the last 90 days - buying. Lifetime open-market purchases: $100K. Historical track record: 5/5 stars across 5 tracked purchases.
Profile
Pasha Sarraf is a corporate insider at Cue Biopharma, Inc. (CUE). Sarraf has reported 5 insider filings with the SEC since 2026. The most recent filing was in July 2026.
| Role | Insider |
|---|---|
| Notability | 20/100 |
Board memberships
- Cue Biopharma, Inc.
Awards & honors
- Insider filing for Cue Biopharma, Inc. (CIK 0002059447) dated 2026-01-02
- No purchases or sales reported in the latest filing
Track Record
InsiderAlpha computes a forward-return-based score for every insider with enough Form 4 purchase history. The metrics below reflect realised performance after each tracked open-market purchase.
| InsiderAlpha rating | ★★★★★ (5/5) |
|---|---|
| Total purchases tracked | 5 |
| Purchases with forward-return data | 5 |
| 30-day win rate | 100% |
| 90-day win rate | 0% |
| Avg 5-day return | +26.52% |
| Avg 30-day return | +19.48% |
| Avg 90-day return | -25.26% |
| Best 30-day return | +19.48% |
Trading Pattern
InsiderAlpha's records for Pasha Sarraf go back to 2026: 3 primary Form 4 filings, an average of 3.0 per year. The typical open-market purchase is $20K (5 buys totaling $100K). The largest single buy on record is $28K of CUE in 2026. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Career & Filing History
Every role Pasha Sarraf has reported on a Form 4, reconstructed from the filings themselves - reporting insiders must state their relationship to the issuer (officer title, director seat, or 10% ownership) on every filing.
- Insider at Cue Biopharma, Inc. (CUE) - 1 filing, 2026
- Insider at Cue Biopharma, Inc. (CUE) - 2 filings, 2026
Recent Transactions
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-10 | CUE | Cue Biopharma, Inc. | A - Grant or award | 21.8K | $0.00 | |
| 2026-01-02 | CUE | Cue Biopharma, Inc. | P - Open-market purchase | 77.4K | $0.30 | $23K |
| 2026-01-02 | CUE | Cue Biopharma, Inc. | P - Open-market purchase | 78.1K | $0.31 | $24K |
| 2026-01-02 | CUE | Cue Biopharma, Inc. | P - Open-market purchase | 86.9K | $0.32 | $28K |
| 2026-01-02 | CUE | Cue Biopharma, Inc. | P - Open-market purchase | 77.1K | $0.30 | $23K |
| 2026-01-02 | CUE | Cue Biopharma, Inc. | P - Open-market purchase | 4.2K | $0.31 | $1K |
Companies - Last 90 Days
- Cue Biopharma, Inc. (CUE) - 1 filing, last 2026-07-10
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades at the companies Pasha Sarraf has recently filed at. Multiple unrelated insiders buying the same stock within a short window - cluster buying - has historically been one of the strongest Form 4 signals.
- Shao-Lee Lin - $1000K of CUE open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
- Paresh Patel
- PAULSON CO. INC.
- John Paulson
- Pentwater Capital Management LP
- Bryan Douglas Pereboom
- Gjorgi Popstefanov
- Adam D. Portnoy
- David Portnoy
Frequently Asked Questions
Who is Pasha Sarraf?
Pasha Sarraf is a corporate insider at Cue Biopharma, Inc. (CUE). Sarraf has reported 5 insider filings with the SEC since 2026. The most recent filing was in July 2026.…
How many SEC Form 4 filings has Pasha Sarraf submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Pasha Sarraf been buying or selling stock?
Recorded transactions: 5 open-market purchases ($100K) and 0 open-market sales across all tracked filings.
How accurate is Pasha Sarraf's historical track record?
Across 5 tracked purchases, Pasha Sarraf averaged +19.5% avg 30-day return with a 100% 30-day win rate. InsiderAlpha rates the track record at 5/5 stars.
Where can I see all of Pasha Sarraf's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Open the live Pasha Sarraf profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.